Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.

Larissa A. Korde,Mark R. Somerfield,Lisa A. Carey,Jennie R. Crews,Neelima Denduluri,E. Shelley Hwang,Seema A. Khan,Sibylle Loibl,Elizabeth A. Morris,Alejandra Perez,Meredith M. Regan,Patricia A. Spears,Preeti Sudheendra,W. Fraser Symmans,Rachel L. Yung,Brittany E. Harvey,Dawn L. Hershman

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.

2021

Larissa A. Korde
Mark R. Somerfield
Lisa A. Carey
Jennie R. Crews
Neelima Denduluri
E. Shelley Hwang
Seema A. Khan
Sibylle Loibl
Elizabeth A. Morris
Alejandra Perez
Meredith M. Regan
Patricia A. Spears
Preeti Sudheendra
W. Fraser Symmans
Rachel L. Yung
Brittany E. Harvey
Dawn L. Hershman

PURPOSETo develop guideline recommendations concerning optimal neoadjuvant therapy for breast cancer.METHODSASCO convened an Expert Panel to conduct a systematic review of the literature on neoadju...

Keywords:

Regimen
Medicine
Targeted therapy
Internal medicine
Oncology
Neoadjuvant therapy
Inflammatory breast cancer
Breast cancer
Carboplatin
Guideline
Hormone therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

132

References

Citations